Nonsense Tx
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at Nonsense Tx
Lev Osherovich
Co-founder and CSO
Nonsense Tx Email Formats
Nonsense Tx uses 2 email formats. The most common is {first initial} (e.g., j@nonsensetx.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@nonsensetx.com | 50% |
{first name} | john@nonsensetx.com | 50% |
About Nonsense Tx
Nonsense mutations cause about 10-12% of cases across over 10,000 rare diseases, impacting roughly 40 million people. These mutations often lead to the most severe disease outcomes. At Nonsense Tx, we focus on developing small-molecule therapies to boost collagen 7 production for Dystrophic EB patients. 35% of RDEB patients have at least one nonsense mutation. Early lab results using primary patient cells—tested with a leading expert on nonsense mutations in EB—have shown very promising outcomes
Nonsense Tx revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Nonsense Tx has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Nonsense Tx has never raised funding before.
Germany
Spain
United Kingdom
United Arab Emirates
South Africa
Canada
Australia
United StatesFrequently asked questions
4.8
40,000 users
